ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Revolo Biotherapeutics Limited

Revolo Biotherapeutics Limited is an active company incorporated on 31 October 2011 with the registered office located in Cambridge, Cambridgeshire. Revolo Biotherapeutics Limited was registered 13 years ago.
Status
Active
Active since incorporation
Company No
07828414
Private limited company
Age
13 years
Incorporated 31 October 2011
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 31 October 2024 (10 months ago)
Next confirmation dated 31 October 2025
Due by 14 November 2025 (2 months remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 March 2025
Due by 31 December 2025 (3 months remaining)
Contact
Address
C/O Bcs Windsor House, Station Court
Station Road
Great Shelford
Cambridgeshire
CB22 5NE
England
Same address for the past 6 years
Telephone
01438906978
Email
Available in Endole App
People
Officers
9
Shareholders
71
Controllers (PSC)
1
Director • President And Ceo • American • Lives in United States • Born in Aug 1964
Director • Swiss • Lives in Switzerland • Born in Sep 1969
Director • Physician • American • Lives in United States • Born in Aug 1956
Director • Ceo • American • Lives in United States • Born in Feb 1970
Director • Attorney (Retired), Board Member • American • Lives in United States • Born in Feb 1956
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Coventry City Football Club Limited
BCS Cosec Limited is a mutual person.
Active
Ir 2018 Limited
BCS Cosec Limited and Jones Woodrow Bryan are mutual people.
Active
Brimadell Property Developments Limited
BCS Cosec Limited is a mutual person.
Active
Vactpoon Limited
BCS Cosec Limited is a mutual person.
Active
Lansharks (UK) Limited
BCS Cosec Limited is a mutual person.
Active
Acrecrest Properties Limited
BCS Cosec Limited is a mutual person.
Active
Propdoc Limited
BCS Cosec Limited is a mutual person.
Active
Covalab UK Limited
BCS Cosec Limited is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Mar 2024
For period 31 Mar31 Mar 2024
Traded for 12 months
Cash in Bank
£5.69M
Decreased by £10.17M (-64%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£6.82M
Decreased by £13.08M (-66%)
Total Liabilities
-£3.76M
Decreased by £3.35M (-47%)
Net Assets
£3.06M
Decreased by £9.73M (-76%)
Debt Ratio (%)
55%
Increased by 19.37% (+54%)
Latest Activity
David Peabody Southwell Resigned
3 Months Ago on 19 May 2025
New Charge Registered
6 Months Ago on 4 Mar 2025
Confirmation Submitted
9 Months Ago on 13 Nov 2024
Full Accounts Submitted
1 Year 2 Months Ago on 19 Jun 2024
Jonathan Michael Norman Rigby Resigned
1 Year 8 Months Ago on 3 Jan 2024
Jones Woodrow Bryan Appointed
1 Year 8 Months Ago on 3 Jan 2024
David Peabody Southwell Appointed
1 Year 8 Months Ago on 15 Dec 2023
Confirmation Submitted
1 Year 10 Months Ago on 3 Nov 2023
Full Accounts Submitted
2 Years Ago on 25 Aug 2023
Ms Marla Susan Persky Details Changed
2 Years 7 Months Ago on 9 Feb 2023
Get Credit Report
Discover Revolo Biotherapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Termination of appointment of David Peabody Southwell as a director on 19 May 2025
Submitted on 30 May 2025
Statement of capital following an allotment of shares on 14 February 2025
Submitted on 19 Mar 2025
Registration of charge 078284140002, created on 4 March 2025
Submitted on 5 Mar 2025
Confirmation statement made on 31 October 2024 with updates
Submitted on 13 Nov 2024
Statement of capital following an allotment of shares on 24 June 2024
Submitted on 5 Sep 2024
Statement of capital following an allotment of shares on 31 March 2024
Submitted on 27 Jun 2024
Total exemption full accounts made up to 31 March 2024
Submitted on 19 Jun 2024
Appointment of David Peabody Southwell as a director on 15 December 2023
Submitted on 27 Mar 2024
Statement of capital following an allotment of shares on 13 February 2024
Submitted on 11 Mar 2024
Appointment of Jones Woodrow Bryan as a director on 3 January 2024
Submitted on 29 Feb 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year